A detailed history of Groupama Asset Managment transactions in Abbott Laboratories stock. As of the latest transaction made, Groupama Asset Managment holds 228,448 shares of ABT stock, worth $26.9 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
228,448
Previous 186,891 22.24%
Holding current value
$26.9 Million
Previous $19.4 Billion 7.68%
% of portfolio
0.54%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$100.07 - $118.13 $4.16 Million - $4.91 Million
41,557 Added 22.24%
228,448 $20.9 Billion
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $1.14 Million - $1.27 Million
-11,279 Reduced 5.69%
186,891 $19.4 Billion
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $4.79 Million - $5.29 Million
-43,750 Reduced 18.08%
198,170 $26.1 Billion
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $21.8 Million - $26.7 Million
241,920 New
241,920 $26.6 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.